Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Ranjit Kapadia

    Jump to

    • Here's why pharma sector will continue outperforming

    • Sell Ranbaxy; target Rs 270: Ranjit Kapadia

    • How experts are reading Dr Reddy's Laboratories Q3 results

    • Except Japan, Lupin saw good growth in all mkts: Centrum

    • Time Technoplast has target of Rs 75: Kapadia

      Time Technoplast has target of Rs 75 over the period of one year, says Ranjit Kapadia, HDFC Securities.

    • Bilcare has target of Rs 808: Kapadia

      Bilcare has target of Rs 808, says Ranjit Kapadia, HDFC Securities.

    • Kapadia positive on Biocon

    • Aurobindo Pharma has target of Rs 1626: Kapadia

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347